ScinoPharm China

	Facilities

	CRO Business

	Intellectual Property

		As our foothold in China and a center for future expansion, ScinoPharm Kunshan serves as a center for drug process development and for contract research and development . To address the demands of both multinational companies and local formulation companies, ScinoPharm is constructing a new GMP plant in Changshu, Jiangsu Province. The plant, slated to be fully operational by 2011, will be used for the production of GMP grade pharmaceutical intermediates initially, and later be equipped to handle API production.

ScinoPharm Kunshan(SPK)

To capitalize on the availability and lower cost of highly educated chemists in China, ScinoPharm had opened another site in KunShan, China, near Shanghai. This location is also equipped with a kilo lab that provides the capability to quickly scale up various processes before further optimization. KunShan site specializes in process R&D and Kilo Lab testing and small-scale manufacturing.

It is designed to supplement our efforts in Taiwan, especially in the field of generic drug synthesis and general technical service to the parent company. With lower operating costs in China, ScinoPharm can provide cost-effective complementary services to our parent company thus allowing our customers more choices at lower costs for projects that they outsource.

ScinoPharm Changshu (SPC)

ScinoPharm has commenced construction of a new plant on a 66,670 square meter site. The facilities, located in Changshu, Jiangsu province in China, will include a R&D centre and production plants fully compliant with U.S. and international GMP standards. The Changshu plant, slated to be fully completed by 2012, will be used for the production of GMP grade pharmaceutical intermediates initially, and later be equipped to handle API production. China’s market for better quality APIs has grown considerably, and local formulation companies are encouraged to utilize APIs from companies having DMFs filed in advanced countries. ScinoPharm will close its site in Kunshan and relocate to Changshu by Q3 2011.